IRIS Accounts Production v24.1.4.33 00381927 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh003819272023-03-31003819272024-03-31003819272023-04-012024-03-31003819272022-03-31003819272022-04-012023-03-31003819272023-03-3100381927ns15:EnglandWales2023-04-012024-03-3100381927ns14:PoundSterling2023-04-012024-03-3100381927ns10:Director12023-04-012024-03-3100381927ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3100381927ns10:SmallEntities2023-04-012024-03-3100381927ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3100381927ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3100381927ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3100381927ns10:FullAccounts2023-04-012024-03-3100381927ns10:OrdinaryShareClass12023-04-012024-03-3100381927ns10:Director22023-04-012024-03-3100381927ns10:CompanySecretary12023-04-012024-03-3100381927ns10:RegisteredOffice2023-04-012024-03-3100381927ns5:CurrentFinancialInstruments2024-03-3100381927ns5:CurrentFinancialInstruments2023-03-3100381927ns5:ShareCapital2024-03-3100381927ns5:ShareCapital2023-03-3100381927ns5:CapitalRedemptionReserve2024-03-3100381927ns5:CapitalRedemptionReserve2023-03-3100381927ns5:FurtherSpecificReserve3ComponentTotalEquity2024-03-3100381927ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-3100381927ns5:RetainedEarningsAccumulatedLosses2024-03-3100381927ns5:RetainedEarningsAccumulatedLosses2023-03-3100381927ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3100381927ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3100381927ns5:DeferredTaxation2023-03-3100381927ns5:DeferredTaxation2024-03-3100381927ns10:OrdinaryShareClass12024-03-3100381927ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-31
REGISTERED NUMBER: 00381927 (England and Wales)











Newton (Liver) Limited

Unaudited Financial Statements

for the Year Ended 31 March 2024






Newton (Liver) Limited (Registered number: 00381927)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


Newton (Liver) Limited

Company Information
for the Year Ended 31 March 2024







Directors: F P Ashcroft
J A Levy





Secretary: Mrs J S Levy





Registered office: Mynshull House
78 Churchgate
Stockport
Cheshire
SK1 1YJ





Registered number: 00381927 (England and Wales)





Accountants: Warr & Co Limited
Chartered Accountants
Mynshull House
78 Churchgate
Stockport
Cheshire
SK1 1YJ

Newton (Liver) Limited (Registered number: 00381927)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £   
Fixed assets
Investment property 4 2,180,000 2,180,000

Current assets
Debtors 5 20,128 68,111
Cash at bank 114,695 10,526
134,823 78,637
Creditors
Amounts falling due within one year 6 (90,178 ) (138,401 )
Net current assets/(liabilities) 44,645 (59,764 )
Total assets less current liabilities 2,224,645 2,120,236

Provisions for liabilities 7 (86,972 ) (86,972 )
Net assets 2,137,673 2,033,264

Capital and reserves
Called up share capital 8 1,359 1,359
Capital redemption reserve 7,741 7,741
Fair value reserve 9 370,776 370,776
Retained earnings 1,757,797 1,653,388
Shareholders' funds 2,137,673 2,033,264

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Newton (Liver) Limited (Registered number: 00381927)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 July 2024 and were signed on its behalf by:





F P Ashcroft - Director


Newton (Liver) Limited (Registered number: 00381927)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. Statutory information

Newton (Liver) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding value added tax.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. Employees and directors

The average number of employees during the year was 2 (2023 - 2 ) .

Newton (Liver) Limited (Registered number: 00381927)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. Investment property
Total
£   
Fair value
At 1 April 2023
and 31 March 2024 2,180,000
Net book value
At 31 March 2024 2,180,000
At 31 March 2023 2,180,000

Fair value at 31 March 2024 is represented by:
£   
Valuation in 2024 2,180,000

If investment property had not been revalued it would have been included at the following historical cost:

31.3.24 31.3.23
£    £   
Cost 1,722,252 1,722,252

Investment property was valued on an open market basis on 31 March 2024 by the directors .

5. Debtors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Trade debtors 19,790 14,642
Other debtors 338 53,469
20,128 68,111

6. Creditors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Trade creditors 33,585 32,438
Corporation tax 39,892 25,972
Social security and other taxes 2,985 2,125
Other creditors 4,166 4,166
Directors' current accounts - 65,000
Accruals and deferred income 9,550 8,700
90,178 138,401

Newton (Liver) Limited (Registered number: 00381927)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

7. Provisions for liabilities
31.3.24 31.3.23
£    £   
Deferred tax 86,972 86,972

Deferred
tax
£   
Balance at 1 April 2023 86,972
Balance at 31 March 2024 86,972

8. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
1,359 Ordinary £1 1,359 1,359

9. Reserves
Fair
value
reserve
£   
At 1 April 2023
and 31 March 2024 370,776